- Satellos Bioscience press release (OTC:MSCLF): FY GAAP EPS of -C$0.18
- Satellos had cash and cash equivalents and short-term investments of C$39.6 million as of December 31, 2023, compared with C$1.9 million at December 31, 2022.
0
Satellos Bioscience reports FY results (OTCMKTS:MSCLF)
